This Fund is Soft Closed and is not currently available to new investors

Biotechnology Fund

Equity investors in medical innovation

Launch Date31.10.2013
Base CurrencyUS$
DenominationsUS$ / GBP / EUR
DomicileDublin, Ireland
IndexNASDAQ Biotechnology
US$32.40
US$ Class I Dist
NAV per share 10.08.2020
£593.5mAUM

AUM 31.07.2020

Holdings
70.28% Active Share
As at 31.07.2020